Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lund

Showing results (271-280 of 285) with videos related to

Pageof 29
Sort By:
Alimentary Pharmacology & Therapeutics|October 22, 2025
Research Communication: Teriflunomide Does Not Affect Gluten-Specific T-Cell Activity in Coeliac Disease-A Randomised, Placebo-Controlled TrialLouise F Risnes, Margit Brottveit, Ida Robertsen, et al.
AJOB Empirical Bioethics|June 14, 2021
Deliberations with American Indian and Alaska Native People about the Ethics of Genomics: An Adapted Model of Deliberation Used with Three Tribal Communities in the United StatesErika Blacksher, Vanessa Y Hiratsuka, Jessica W Blanchard, et al.
Molecular Cell|September 1, 2009
RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cellsUlrik Doehn, Camilla Hauge, Scott R Frank, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
Blood|January 30, 2010
Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regenerationMakiko Ohki, Yuichi Ohki, Makoto Ishihara, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 13, 2001
The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesisL H Engelholm, B S Nielsen, S Netzel-Arnett, et al.
Diabetes & Metabolism|May 22, 2017
Informal caregiving as a risk factor for type 2 diabetes in individuals with favourable and unfavourable psychosocial work environments: A longitudinal multi-cohort studyJ Mortensen, A J Clark, T Lange, et al.
Journal of Community Genetics|February 3, 2026
Virtual deliberation on genetics research: report-out of key themes from Diné (Navajo) research & healthcare professionalsCarissa A Sherman, Luke C Nez, Kaja M Aagaard, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
ACS Applied Materials & Interfaces|February 20, 2024
Hierarchically Structured Metal-Organic Framework Polymer Composites for Chemical Warfare Agent DegradationSachini D Perera, Rebecca M Johnson, Robert Pawle, et al.
Pageof 29

Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
Alimentary Pharmacology & Therapeutics|October 22, 2025
Research Communication: Teriflunomide Does Not Affect Gluten-Specific T-Cell Activity in Coeliac Disease-A Randomised, Placebo-Controlled TrialLouise F Risnes, Margit Brottveit, Ida Robertsen, et al.
AJOB Empirical Bioethics|June 14, 2021
Deliberations with American Indian and Alaska Native People about the Ethics of Genomics: An Adapted Model of Deliberation Used with Three Tribal Communities in the United StatesErika Blacksher, Vanessa Y Hiratsuka, Jessica W Blanchard, et al.
Molecular Cell|September 1, 2009
RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cellsUlrik Doehn, Camilla Hauge, Scott R Frank, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
Blood|January 30, 2010
Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regenerationMakiko Ohki, Yuichi Ohki, Makoto Ishihara, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 13, 2001
The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesisL H Engelholm, B S Nielsen, S Netzel-Arnett, et al.
Diabetes & Metabolism|May 22, 2017
Informal caregiving as a risk factor for type 2 diabetes in individuals with favourable and unfavourable psychosocial work environments: A longitudinal multi-cohort studyJ Mortensen, A J Clark, T Lange, et al.
Journal of Community Genetics|February 3, 2026
Virtual deliberation on genetics research: report-out of key themes from Diné (Navajo) research & healthcare professionalsCarissa A Sherman, Luke C Nez, Kaja M Aagaard, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
ACS Applied Materials & Interfaces|February 20, 2024
Hierarchically Structured Metal-Organic Framework Polymer Composites for Chemical Warfare Agent DegradationSachini D Perera, Rebecca M Johnson, Robert Pawle, et al.
Pageof 29